3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

Abstract Background Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but wee...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Seth Helfenstein, Oliver Riesterer, Urs R. Meier, Alexandros Papachristofilou, Benjamin Kasenda, Miklos Pless, Sacha I. Rothschild
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2019-02-01
Seri Bilgileri:	Radiation Oncology
Konular:	Head and neck squamous carcinoma Chemo-radiotherapy Treatment Cisplatin Dose
Online Erişim:	http://link.springer.com/article/10.1186/s13014-019-1235-y
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!